Key Dates

Related Announcements

• December 9, 2024 - Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed). See NOFO PAR-24-289.
• December 9, 2024 - Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed). See NOFO PAR-25-230. 

Issued by

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

The purpose of this Notice is to extend the expiration date for PAR-24-289 “Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)” from September 06, 2025, to December 6, 2025. The last day applications will be accepted is December 5, 2025.

Currently, reads:

Application Due Date(s)

All applications are due by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date: September 6, 2025

Modified to read:

Application Due Date(s)

All applications are due by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date: December 6, 2025

All other aspects of this NOFO remain unchanged.

Inquiries

Please direct all inquiries to:

Heiyoung Park, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-5032
Email: [email protected]